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Abstract  
The potential benefits of dietary long-chain polyunsaturated fatty acids to fish include improved 
growth, survival and stress resistance, reproduction and regulation of immune function. The 
metabolism of eicosapentaenoic acid (EPA; 20:5n-3) and arachidonic acid (ARA; 20:4n-6) into 
short-lived hormones know as eicosanoids play central roles in the regulation of these responses. 
However, little is known about the EPA and ARA requirements and their effect on fatty acid and 
eicosanoid metabolism in barramundi (Lates calcarifer). Therefore, a two part experiment was 
conducted to assess the response of juvenile barramundi (initial weight = 10.3 ± 0.03 g; mean ± S.D.) 
fed one of five diets with graded levels of EPA (diets EPA 1.2, EPA, 4.5, EPA 9.5, EPA 17.0, EPA 
20.1) or one of four diets with graded levels of ARA (diets ARA 1.1, ARA 5.3, ARA 11.5 and ARA 
16.4) compared against a fish oil control diet. A six week feeding trial demonstrated that the addition 
of EPA or ARA did not have any impact on growth performance or feed utilisation. Analysis of the 
whole body fatty acid composition showed that these fatty acids reflected those of the diets. The 
retention and marginal utilisation efficiency suggests that dietary ARA and to a lesser extent EPA are 
required in juvenile barramundi; however, a modified metabolic response was observed. The partial 
cDNA sequences of genes regulating eicosanoid biosynthesis were identified in barramundi tissues, 
namely cyclooxygenase 1 (Lc COX1a, Lc COX1b), cyclooxygenase 2 (Lc COX2) and lipoxygenase 
(Lc ALOX-5). Both COX2 and ALOX-5 expression in the liver tissue were elevated in response to 
increasing dietary ARA, meanwhile expression levels of Lc COX2 and the mitochondrial fatty acid 
oxidation gene Lc CPT1a were elevated in the kidney. Dietary EPA levels had little effect on the 
expression of eicosanoid biosynthesis genes in the liver or kidney. The present study demonstrates 
that consideration should be given to the ARA supply for juvenile barramundi in light of pro-
inflammatory and inducible nature of the cyclooxygenase and lipoxygenase enzymes.  
 
  
Introduction 
Eicosapentaenoic (EPA; 20:5n-3) and arachidonic acid (ARA; 20:4n-6) are important for many 
metabolic and physiological functions, and are precursor molecules for the production of eicosanoid 
hormones that play a role in the inflammatory response, immune function and regulation as well as 
ionic regulation and reproduction in fish and mammals (Calder, 2004; Rowley et al., 1995). In 
humans, the incidence of diseases involving inflammatory processes can be related to the production 
these eicosanoids, for example prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) that are derived 
from high cellular concentrations of ARA (Tocher, 2015; Wall et al., 2010). The cyclooxygenase 
(COX; prostaglandin G/H synthase) and lipoxygenase (LOX; arachidonate 5-lipoxygenase) enzymes 
interact and compete for the EPA and ARA substrates and as such the eicosanoids produced are 
determined by their availability (Calder, 2012; Tocher, 2003).  
The COX enzyme catalyses 20-carbon chain fatty acids (ARA or EPA) through bis-dioxygenation 
and subsequent reduction to produce 2 - and 3 - series prostaglandins (PGG2/3 and PGH2/3) that are 
substrates for the synthesis of biologically active PGs, prostacyclins and thromboxanes (Calder, 
2012; Rouzer and Marnett, 2009; Rowley et al., 1995). While the LOX enzyme catalyses the same 
substrates to yield biologically active metabolites of hydroperoxy-eicosatetraenoic acid (HPETE) 
such as leukotrienes and lipoxins (Matsumoto et al., 1988; Rowley et al., 1995). Unlike most 
vertebrate organisms, the COX enzyme system in teleost fish is further complicated by an 
evolutionary duplication event that led to alternative chromosomal regions of COX genes, often 
identified as ‘a and b’ isoforms of either the COX-1 or -2 series, but rarely both (Ishikawa and 
Herschman, 2007; Ishikawa et al., 2007b). There is also an accepted paradigm that COX-1 is 
constitutively expressed whereas COX-2 is inducible, however this is now widely viewed as an 
oversimplified as inducible COX-1 genes and constitutively expressed COX-2 genes have been 
identified (Breder et al., 1995; Cha et al., 2006; Olsen et al., 2012; Rouzer and Marnett, 2009). 
It has been shown in rainbow trout (Oncorhynchus mykiss) cell lines that fatty acids such as 18:4n-3 
and 20:4n-3, can reduce the production of 2-series prostanoids and 4-series leukotrienes by 
conversion to EPA and subsequent competition with ARA (Ghioni et al., 2002). In many vertebrate 
and fish species, EPA and ARA are required for important metabolic and physiological functions, 
and the optimal as well as dietary requirements are well understood (Bell and Sargent, 2003; Das, 
2006; Glencross, 2009; Izquierdo, 1996; Tocher, 2010; Tocher, 2015). In addition, there is great 
potential for dietary ARA to affect growth, stress response, immune response and survival, 
particularly at early life stages (Atalah et al., 2011a; Atalah et al., 2011b; Bell and Sargent, 2003; 
Castell et al., 1994; Montero et al., 2015b; Norambuena et al., 2016; Yuan et al., 2015). 
Information on the EPA and ARA requirements in the barramundi or Asian seabass (Lates 
calcarifer) are scarce. In the only study available thus far, increased levels of dietary ARA in the 
absence of EPA showed negative effects on fish health, including disproportionate tissue LC-PUFA 
retention and pathophysiological effects such as subcutaneous haemorrhaging and disrupted ionic 
regulation (Glencross and Rutherford, 2011). There is evidence to suggest that wild barramundi 
(either from fresh or salt water) can contain ARA levels more than 5-fold higher than EPA in their 
tissues (Nichols et al., 2014). The increasing use of alternative oils in farmed fish, often containing 
high levels of omega 6 fatty acids which can act as ARA precursors (eg. soybean oil, sunflower oil) 
may present issues associated with modified lipid metabolism (Brown and Hart, 2011).  
Based on previous observations, the present study hypothesised that the effect of changing the 
dietary ARA or EPA level may significantly modify fatty acid metabolism in barramundi. A two 
part, dose-response experimental design was used to determine the effect of increasing the dietary 
EPA and ARA. To achieve this, commercial preparations of an EPA rich fish oil and an ARA rich 
fungal oil were incrementally added to a series of barramundi diets. It was also hypothesised that 
there may be effects on the transcription of genes involved in eicosanoid synthesis. The genes 
regulating eicosanoid synthesis have not been identified in barramundi, and no information is 
available on their nutritional regulation. 
 
Materials and methods 
Ingredient and diet preparation 
A single basal diet was formulated and prepared without the addition of dietary oils (lipids). The dry 
ingredients were passed separately through a hammermill (Mikro Pulverizer, type 1 SH, New Jersey, 
USA) such that the maximum particle size was less than 750 µm. All dry ingredients were then 
thoroughly mixed using an upright commercial mixer (Bakermix, Model 60 A-G, NSW, Australia). 
Fish meal was defatted prior to use by manually mixing n-hexane and fish meal (2:1 respectively) in 
a large drum. The mix was left to soak for 3h before draining the excess hexane and repeating the 
process a second time. The fish meal was oven dried overnight at 60 ˚C to a constant dry matter. The 
chemical composition of the main dietary ingredients is presented in Table 1. The single batch of 
basal diet was produced using a laboratory-scale twin-screw extruder with intermeshing, co-rotating 
screws (MPF24, Baker Perkins, Peterborough, United Kingdom). The pellets were extruded through 
a 2 mm tapered die and obtained a 1.5-fold increase in diameter by expansion. The pellets were cut 
off at lengths of 3-4 mm using a variable speed 4-blade cutter and dried overnight at 60 ˚C to a 
constant dry matter. The dietary treatments were generated by vacuum-infusion of the different lipid 
sources (lipid added at 8.2% diet) to batches of dried pellets. Five dietary treatments were formulated 
with increasing eicosapentaenoic acid (added via; Incromega™ TG500, CRODA, United Kingdom) 
up to 20.1 g/kg inclusion (EPA 1.2, EPA, 4.5, EPA 9.5, EPA 17.0, EPA 20.1) and four treatments 
were formulated with increasing arachidonic acid (added via; ARASCO®, Martek Biosciences, USA) 
up to 16.4 g/kg inclusion (ARA 1.1, ARA 5.3, ARA 11.5 and ARA 16.4). A diet containing only fish 
oil was used as a unique control for both experiments (FO CTRL). The diets were then stored at -20 
˚C until required. The formulation and chemical composition of the ten diets are presented in Table 
2. 
Barramundi husbandry and growth 
Juvenile barramundi (Lates calcarifer) were sourced from the Betta Barra fish hatchery (Atherton, 
QLD, Australia), on-grown in a 10,000L tank and fed a commercial diet (Marine Float; Ridley 
Aquafeed, Narangba, QLD, Australia). Prior to commencement of the experiment the fish were 
transferred to a series of experimental tanks (1000L) with flow-through seawater (salinity =38 PSU; 
dissolved oxygen 5.4 ± 0.01 mg /L) of 28.9 ± 0.01 ºC (mean ± SD) at a flow rate of about 3 L/min 
being supplied to each of the tanks. At the beginning of the experiment, each of the tanks held 30 
fish of 10.3 ± 0.1 g (mean ± SD, n = 900 individually weighed fish). The two experiments were 
nested within one and conducted simultaneously utilising a common control diet for both 
experiments. The ten experimental diets were therefore randomly distributed amongst thirty tanks 
with each treatment having three replicate tanks. The fish were restrictively fed a sub-satietal 
(approximately 80%) pair-feeding regime in order to avoid the potentially confounding issue of 
unregulated feed intake (Glencross et al., 2003a). 
Sample collection, preparation and digestibility analysis 
Ethical clearance was approved (Approval A05/2014) for the experimental procedures by the CSIRO 
animal ethics committee. Six fish of similar size from the original stock were euthanized by an 
overdose of AQUI-S™ (Lower Hutt, New Zealand) at the beginning of the experiment and stored at 
-20 ºC until analysis. A further three fish from each treatment were euthanized upon termination of 
the experiment and they were frozen at -20 ºC until analysis. 
Upon termination of the growth assay, faeces were collected using established abdominal stripping 
protocols (Blyth et al., 2014). Briefly, the fish were netted from their tanks and anesthetised, then 
gentle abdominal pressure was applied to the distal intestine to extract the faeces. Care was taken by 
the operator to avoid contamination of the sample with foreign material and hands were rinsed after 
each stripping. The faecal sample was placed into a small plastic vial on ice before being stored in a 
freezer -20˚C until analysis.  
Chemical analysis 
Prior to analysis the diets were each ground to a fine powder using a bench grinder (KnifeTec™ 
1095, FOSS, Denmark). The initial and final fish were processed using the following method. The 
frozen whole fish were passed through a commercial meat mincer (MGT – 012, Taiwan) twice to 
obtain a homogeneous mixture. A sample was taken for dry matter analysis and another sample was 
freeze-dried along with the faecal samples until no further loss of moisture was observed (Alpha 1-4, 
Martin Christ, Germany). Dry matter was calculated by gravimetric analysis following oven drying 
at 105ºC for 24 h. Crude protein was calculated after the determination of total nitrogen by organic 
elemental analysis (CHNS-O Flash 2000, Thermo Scientific, USA), based on N x 6.25. Total lipid 
content was determined gravimetrically following extraction of the lipids using chloroform:methanol 
(2:1) following Folch et al. (1957). Gross ash content was determined gravimetrically following loss 
of mass after combustion of a sample in a muffle furnace at 550 ˚C for 24 h. Gross energy was 
determined by adiabatic bomb calorimetry (Parr 6200 Calorimeter, USA). Total yttrium 
concentrations in the diets and faeces were determined after nitric acid digestion in a laboratory 
microwave digester (Ethos One, Milestone, Italy) using inductively coupled plasma-mass 
spectrophotometry (ICP-MS) (ELAN DRC II, Perkin Elmer, USA). 
Fatty acid composition was determined following the methods of Christie (2003). Lipids were 
esterified by an acid-catalysed methylation and 0.3 mg of an internal standard was added to each 
sample (21:0 Supelco, PA, USA). The fatty acids were identified relative to the internal standard 
following separation by gas chromatography (GC). An Agilent Technologies 6890N GC system 
(Agilent Technologies, California, USA) fitted with a DB-23 (60m x 0.25mm x 0.15 μm, cat 122-
2361 Agilent Technologies, California) capillary column and flame ionisation detection was used. 
The temperature program was 50–175 ºC at 25 ºC /min then 175–230 ºC at 2.5 ºC /min. The injector 
and detector temperatures were set at 250 ºC and 320 ºC, respectively. The column head pressure 
was set to constant pressure mode at 170 kPa using hydrogen as the carrier gas. The peaks were 
identified by comparing retention times to the internal standard and further referenced against known 
standards (37 Comp. FAME mix, Supelco, PA, USA). The resulting peaks were then corrected by 
the theoretical relative FID response factors (Ackman, 2002) and quantified relative to the internal 
standard. 
Cloning of putative prostaglandin G/H synthase (COX) and arachidonate 5-lipoxygenase (LOX) 
genes 
Sequences of the prostaglandin G/H synthase and arachidonate 5-lipoxygenase (COX1a, COX1b, 
COX2 andALOX-5) genes from several teleost species were identified in the Genbank database. 
Highly conserved regions from protein alignments across species were used to design pairs of 
degenerate primers that were subsequently synthesised by Sigma-Aldrich (Table 3). Pooled 
barramundi liver cDNA (1000 ng) was amplified in reactions, with each degenerate primer pair (F 
and R; 10 μm) using platinum TAQ mix (Thermofisher). Polymerase chain reaction (PCR) 
conditions including an initial denaturation step at 90°C for 2 min followed by 35 cycles of 94°C/10 
s, 50°C/30 s (50% ramp speed) and 72°C/30 s with a final extension step of 72°C/5 min were used. 
The amplification products were separated by size using electrophoresis on a 1% agarose gel and 
then excised and extracted using the QIA quick gel extraction kit (QIAGEN). The target was then 
ligated using the pGEM-T Easy vector system (Promega). Ligation reactions were then transformed 
onto One Shot TOP10 chemically competent Escherichia coli cells (Thermofisher) which were then 
cultured overnight on LB ampicillin plates (100 μg/mL). Positive clones were selected by PCR 
amplification with primers flanking the multiple cloning site (M13F and M13R), using an initial 
denaturation step at 94°C/5 min followed by 35 cycles of 94°C/20 s, 55°C/30 S, 72°C/1.5 min with a 
final extension step of 72°C/5 min. Randomly selected positive clones were prepared for sequencing 
with a QIAprep Miniprep kit (QIAGEN) and then the plasmid insert was sequenced using the 
BigDye® Terminator V3.1 sequencing kit (Applied Biosystems) with an ABI 3130 Automated 
Capillary DNA Sequencer (Applied Biosystems). 
Sequencing analysis 
Multiple alignments of the target genes (Lc COX-1a, Lc COX-1b, Lc COX-2 and Lc ALOX-5) were 
made using the CLC Genomics Workbench software (CLC Bio, Aarhus, Denmark). The ORF and 
amino sequence alignment and analysis were conducted using the Create Alignment tool, and 
confirmed as the target gene sequence using the BLASTX algorithm 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Sequence analysis of the previously unreported Lates 
calcarifer COX and LOX genes identified expressed sequence tags (EST) of between 752 and 999 
base pairs, open reading frame protein alignments showing similarity with other teleost fish are 
presented in supplementary figures 1 a-d.  
RNA extraction, cDNA synthesis and quantitative real-time RT-PCR 
Total RNA was extracted from the livers and kidneys of fish from the FO CTRL, EPA 1.2, EPA 
20.1, ARA 1.1 and ARA 16.4 treatments using TRIzol® reagent (Invitrogen) according to the 
manufacturer’s instructions. Only the two extreme dietary treatments of each experiment were used 
in this analysis as it was anticipated that only minor differences in gene expression would be 
observed. RNA extraction and cDNA synthesis were performed following previously reported 
methods from the same laboratory (Salini et al., 2015b; Wade et al., 2014). Real-time PCR primers 
specific to each target gene (Table 4) were designed using PerlPrimer v.1.1.17 (Marshall, 2004). 
Quantitative real-time RT-PCR was performed using 2X SYBR Green PCR master mix (Applied 
Biosystems), 0.2 μm RT-PCR primers for each gene and the equivalent of 7.5 ng of reverse 
transcribed RNA following previously reported cycling and processing conditions from the same 
laboratory (Salini et al., 2015b; Wade et al., 2014). Changes in expression levels were normalised for 
each gene to the endogenous reference gene elongation factor 1 alpha (EF1α) and the exogenous 
reference gene Luciferase. The variation in amplification across all samples was very small, 0.57 
cycles and 0.40 cycles for EF1α Luciferase, respectively. The EF1α and Luciferase genes have been 
routinely used as a reference in this species (De Santis et al., 2011; Wade et al., 2014).  
Calculations and statistical analysis 
Differences in the ratio of dry matter, protein, lipid and energy to yttrium in the diet and faeces were 
calculated to determine the apparent digestibility coefficients (ADC) following Maynard and Loosli 
(1979) using the formula: 
𝐴𝐷𝐶 =  (1 − (
𝑌𝑑𝑖𝑒𝑡  × 𝑃𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟𝑓𝑎𝑒𝑐𝑒𝑠
𝑌𝑓𝑎𝑒𝑐𝑒𝑠  × 𝑃𝑎𝑟𝑎𝑚𝑒𝑡𝑒𝑟𝑑𝑖𝑒𝑡
))  × 100 
Where Ydiet and Yfaeces are the yttrium content in the diet and faeces respectively and Parameterfaeces 
and Parameterdiet are the nutritional parameter of concern in the diet and faeces respectively. 
Nutrient retention efficiencies were calculated as the ratio of the nutrient or specific fatty acid gained 
relative to their respective consumption during the study period following Maynard and Loosli 
(1979) using the formula: 
𝑅𝑒𝑡𝑒𝑛𝑡𝑖𝑜𝑛 (%) = (
𝑁𝑓 − 𝑁𝑖
𝑁𝑐
) × 100 
Where Nf and Ni are the nutrient composition in the final and initial fish (g/fish) on a live-basis and 
Nc is the amount of the nutrient consumed (g/fish) during the study period.  
To provide a size independent function for the calculation of maintenance demands and utilisation 
efficiencies of specific fatty acids, modelling of the specific fatty acid retention efficiency data was 
initially carried out (unpublished laboratory study). Live-weight exponents of 0.679 and 0.857 were 
recorded for EPA (20:5n-3) and ARA (20:4n-6) respectively as size independent functions for the 
determination of maintenance demands. Maintenance demands and utilisation efficiencies were then 
determined from the regression of marginal fatty acid intake against marginal fatty acid gain on a 
transformed live-weight basis following (Glencross, 2008) using the formula:  
𝑀𝑎𝑟𝑔𝑖𝑛𝑎𝑙 𝐼𝑛𝑡𝑎𝑘𝑒 𝑜𝑟 𝐺𝑎𝑖𝑛 = 𝐼𝑛𝑡𝑎𝑘𝑒 𝑜𝑟 𝐺𝑎𝑖𝑛 𝐹𝐴 /𝐺𝑀𝑊
𝑥/𝑑 
Where Intake FA or Gain FA is the specific fatty acid consumed or gained (g/fish) on a weight specific 
(geometric mean live-weight g/fish) basis then transformed to a fatty acid specific exponent. The 
duration of the study period in days is defined as d. 
All data are expressed as mean with pooled standard error mean unless otherwise specified. All data 
were checked for normal distribution and homogeneity of variance by qualitative assessment of 
residual and normal Q-Q plots. Growth performance data were analysed using polynomial contrasts 
and all other data were analysed by one-way ANOVA. Levels of significance were compared using 
Tukey’s HSD a posteriori test. The RStudio package v.0.98.501was used for all statistical analyses 
(R Core Team, 2012). Any percentage data were arcsine transformed prior to analysis. Significance 
among the treatments defined as P < 0.05. 
  
Results 
Growth performance and feed utilisation 
The results of the 42 d growth assay demonstrated that the barramundi responded well to the 
experimental diets in both experiments exceeding over 400% of their original weight at a rate of 
more than 1 g/d. The growth parameters for each experiment were analysed separately using 
polynomial contrasts (Table 5 and 6). When the fish were fed increasing EPA there were no 
significant contrasts in any of the growth parameters (Table 5). Similarly, the barramundi did not 
show any significant contrasts in response to the increasing ARA in the second experiment (Table 6). 
The only exception being a slight improvement in FCR with the addition of ARA however the 
numerical differences were minor. There was also a linear improvement in survival with increasing 
ARA. Several moribund fish were removed from the system after a weight check at day 28. These 
fish were considered non-contributing as they had not consumed any feed. Additionally, the growth 
performance of the fish fed different EPA and ARA treatments were compared by one-way ANOVA 
against the control. There were no significant differences in any of the growth parameters measured 
(data not reported).  
Digestibility analysis of the diets 
While no differences were recorded in the digestibility of dry matter, protein or energy across the 
treatments, the digestibility of lipid was significantly higher in the control (FO CTRL) fed fish 
(Table 7). Significantly lower digestibility levels of MUFA and C18PUFA were recorded in the FO 
CTRL compared with other treatments, predominantly from reduced 18:1 and 18:2n-6. Increased 
levels of dietary EPA or DHA resulted in a significantly reduced digestibility of SFA fatty acids, 
predominantly from reduced 18:0. There were numerically minor differences in the digestibility of 
LC-PUFA (20:4n-6, 20:5n-3, 22:5n-3, 22:6n-3). 
Whole-body composition.  
When compared against the control (FO CTRL), there were significant differences in whole body 
composition for many parameters (Table 8). Dry matter was significantly reduced in the EPA 1.2 
treatment compared with all other treatments. This change was reflected in the lipid and energy 
composition, with significantly reduced levels recorded in the EPA 1.2 treatment. Protein 
composition was unaffected by the treatments. As expected, significant elevation of ARA (20:4n-6) 
and EPA (20:5n-3) levels were recorded in the fish fed the ARA 16.4 and EPA 20.1 diets, 
respectively. Increased levels of EPA (20:5n-3) in the EPA 20.1 treatment led to a significant 
increase in DPA levels (22:5n-3) The FO CRTL treatment had significantly elevated DHA (22:6n-3) 
and total SFA.  
Nutrient retention efficiency 
Fatty acid retention efficiency in the control fed fish (FO CTRL) did not differ from the quadratic 
trendlines (Figure 1a-j). There was a quadratic effect on the retention efficiency of 20:4n-6 when 
dietary EPA or ARA increased (Fig1 c, h; Table 9).There was a significant quadratic effect on 20:5n-
3 retention in response to increasing dietary EPA diets with a decrease in retention before increasing 
at the highest inclusion whereas increasing ARA had no effect (Fig.1d, i; Table 9). Retention 
efficiency of 22:6n-3 was not affected by increasing dietary EPA however there was a significant 
quadratic effect in response to increasing dietary ARA with a decrease in retention before increasing 
at the highest inclusion (Fig.1e, j; Table 9).  
Marginal utilisation efficiencies 
The marginal utilisation efficiencies are presented for both EPA and ARA fed fish (Fig. 3a, 3b 
respectively). Based on the linear assessment of marginal EPA intake against marginal EPA gained, 
a significant difference was observed (P<0.01). The positive y intercept value indicates that no 
maintenance demand could be established for 20:5n-3. Using the live-weight exponent value of 
0.679 the EPA fed fish had a 20:5n-3 utilisation efficiency of 62.1% described by the linear equation 
of y = 0.621x + 0.0003, R2 = 0.975 (Fig. 3a). Similarly, there was a significant linear relationship of 
marginal ARA intake against marginal ARA gain (P<0.05). The negative y intercept value suggests 
that a maintenance value of around 0.01 g/kg0.85/d could be determined for 20:4n-6. Using the live-
weight exponent of 0.85 the ARA fed fish had a 20:4n-6 utilisation efficiency of 91.9% described by 
the linear equation of y = 0.919x – 0.011, R2 = 0.965 (Fig. 3b). A summary of the maintenance 
demand and utilisation efficiencies is presented in Table 9. 
Gene identification and quantitative expression 
Partial cDNA sequences of Lc COX1a, Lc COX1b, Lc COX2 and Lc ALOX-5 were identified through 
degenerate PCR. BLAST similarity searches showed that barramundi gene orthologs shared between 
88 and 91 % similarity with other teleost fish at the amino acid level, and protein alignments showed 
similarity with other teleost fish (Supplementary Figure 1a-d). The expression of eicosanoid pathway 
genes (Lc COX1a, Lc COX1b, Lc COX2 and Lc ALOX-5), as well as the mitochondrial ß-oxidation 
gene (Lc CPT1a) were analysed in the liver and kidney by quantitative real-time RT-PCR.  
The expression of all genes analysed was up regulated in the liver of fish fed the EPA 1.2 diet 
compared with the FO CTRL fed fish (Fig. 3). There was a significant difference in the expression of 
Lc COX1b among the EPA 1.2 and EPA 20.1 treatments. No other genes were nutritionally regulated 
in the liver or kidney tissue of fish fed increasing EPA. In the case of the ARA fed fish, expression of 
Lc COX1b, Lc COX2 and Lc CPT1α in the kidney tissue was lowest in the ARA 1.1 and highest in 
the ARA16.4 treatments. Similarly, the expression of Lc COX2 was also significantly up regulated in 
the liver tissue (Fig. 4). 
  
Discussion 
The growth performance of juvenile barramundi in the present study, using a pair-fed feeding 
regime, was not affected by increasing dietary EPA or ARA content. Moreover, the response was 
compared to a control diet containing only fish oil and no significant differences in growth 
performance were reported. Although it is an unlikely real-world scenario to include high levels of 
any one LC-PUFA, these observations and those of a previous study, confirm that there are no 
growth stimulatory effects owing to any individual LC-PUFA in juvenile barramundi (Glencross and 
Rutherford, 2011). In many species, EPA can exert cardio-protective benefits such as lowering 
triglycerides and low-density lipoprotein levels (Aarsland et al., 1990; Cahill et al., 1988; Cottin et 
al., 2011; Wei and Jacobson, 2011; Weiner et al., 1986). Whereas ARA on the other hand, is an 
essential and necessary precursor to the 2-series and 4-series eicosanoids that mediate homeostasis 
during times of environmental or physiological stress (Bell and Sargent, 2003). 
Studies examining the dose-response of EPA in juvenile or growing fish are relatively scarce and 
mostly concentrate on larval fish requirements. However, many studies have investigated 
interactions between DHA, EPA and ARA or n-3 to n-6 ratios in fish and the general consensus is 
that size and species differences exist and that an appropriate balance between these essential fatty 
acids is critical (Sargent et al., 1999; Tocher, 2015). Consistent with the present study, several 
studies in larval and juvenile fish such as the Atlantic salmon Salmo salar (Thomassen et al., 2012), 
cobia Rachycentron canadum (Trushenski et al., 2012), gilthead sea bream Sparus aurata (Atalah et 
al., 2011a), Senegalese sole Solea senegalensis (Villalta et al., 2008), striped jack Pseudocaranx 
dentex (Watanabe et al., 1989) and turbot Scophthalmus maximus (Bell et al., 1995) all concluded 
that EPA does not stimulate an improved growth response. However, larval and juvenile red 
seabream Pagrus major were found to have an EPA requirement with linear improvements in growth 
and survival observed (Furuita et al., 1996; Takeuchi et al., 1990). 
Also in agreement with the present study, a range of larval and juvenile marine species such as 
Atlantic cod Gadus morhua (Bransden et al., 2005), gilthead sea bream Sparus aurata (Alves Martins 
et al., 2012; Atalah et al., 2011a; Fountoulaki et al., 2003), Senegalese sole (Villalta et al., 2005) and 
turbot (Estévez et al., 1999), were able tolerate a wide range of dietary ARA levels with growth and 
survival found to be independent of ARA inclusion. In agreement, several recent studies have further 
demonstrated that balanced ARA and EPA are more critical than either individual FA in terms of 
growth and other metabolic processes further highlighting the need for understanding the optimal 
LC-PUFA balance (Norambuena et al., 2015; Norambuena et al., 2016). 
Many studies, including the present study, have demonstrated that the fatty acid composition of the 
tissues is representative of the profile of the fed diet (Rosenlund et al., 2011). However, the 
efficiency by which fatty acids are retained may represent a more metabolic or biological importance 
to the fish. The DHA retention of the fish in the present study fed increasing EPA did not change. 
However, the EPA and ARA retention were inversely related and responded in a curvilinear fashion. 
The effect was not dramatic however it indicated a point of sensitivity as EPA in the diet increased 
and the barramundi retained more of the endogenous ARA. Glencross and Rutherford (2011) 
reported disproportionate EPA and ARA retention in barramundi however this was likely an effect of 
the increasing DHA level in combination with either EPA or ARA. Atlantic salmon were also shown 
to conserve ARA (Norambuena et al., 2015) while Senegalese sole attempt to synthesise ARA when 
dietary supply is limited (Norambuena et al., 2013). 
A recent study has already suggested that the marginal efficiency of LC-PUFA utilisation are low 
compared to other fatty acids in growing barramundi (Salini et al., 2015a). The present study 
describes a more up to date and relevant assessment of the marginal efficiency of EPA and ARA 
assessed in a dose-response manner, while simultaneously controlling for other LC-PUFA (rather 
than FO substitution). On closer examination of dietary ARA demands in juvenile barramundi, we 
report the maintenance requirement, albeit low, of this fatty acid to be 0.01 g/kg LW0.85/d. This 
confirms that ARA is perhaps unusual in its characteristic metabolic requirement for this species. 
EPA on the other hand is apparently not required for maintenance in juvenile barramundi suggesting 
that they have a very low dietary requirement for this fatty acid and that their endogenous reserves 
are sufficient for maintenance. In addition, the EPA retention figures were modest with a calculated 
intake to gain ratio of 1.6:1 confirming this. This is consistent with other studies on barramundi and 
red sea bream in that EPA is only modestly retained unless there is a gross imbalance of other LC-
PUFA (Glencross et al., 2003b; Glencross and Rutherford, 2011).  
There is a very large body of research into the mechanisms of action of n-3 LC-PUFA on 
inflammatory pathways (Rangel-Huerta et al., 2012). The data from the present study build upon this 
in barramundi by presenting the nutritional regulation of key eicosanoid pathway enzymes. The 
current work verifies that barramundi possess two variants of the cyclooxygenase 1 enzyme (COX1a, 
COX1b) and a single cyclooxygenase 2 (COX2). The fish in the present study were not exposed to 
any form of physical or environmental stressors (apart from being in research aquaria) that could 
cause an inflammatory response and therefore the only trigger for a response is from the diets.  
The gene expression analysis in the present study demonstrated that EPA supplied in excess mostly 
did not affect the gene expression between the treatments in either the liver or kidney tissue. 
However, the slight exception to this was the nutritional regulation of the COX1b isoform in the liver 
of the EPA fed fish. COX1 isoforms are widely distributed and generally constitutively expressed 
however this homeostatic function is now considered to be an oversimplified view (Rouzer and 
Marnett, 2009). In agreement with the present study, there were non-significant yet quite measurable 
differences in COX1b expression in larval tongue sole Cynoglossus semilaevis (Yuan et al., 2015). 
The results of the present study confirm that the COX1b gene in barramundi is inducible however the 
differences warrant further investigation into the potential for pathophysiological effects. Some 
explanation for these inconsistencies may be found in whole-body composition of wild barramundi 
collected from different environments (Nichols et al., 2014; Sinclair et al., 1983). These authors 
found that Northern Australian barramundi, maintain a characteristically high ARA content 
regardless of their environment. Therefore, it is suggested that barramundi can modify the 
transcription of these genes depending on the potentially transient nature of dietary ARA supply.  
The EPA or anti-inflammatory derived eicosanoids are known to be cross-linked with changes in 
transcription of fatty acid synthesis and beta-oxidation genes (Aarsland et al., 1990; Calder, 2007; 
Chen et al., 2014; Sijben and Calder, 2007) . However, the CPT1α expression data in the present 
study are inconsistent in that they are not affected by the inclusion level of either EPA or ARA albeit 
with a slight decrease in the kidney tissue of the ARA1.1 fish. However, our data showed that 
CPT1α expression is elevated in both low and high EPA treatments compared to the control fish. 
Additionally, the ALOX-5 expression was affected in much the same way as CPT1α and this may 
suggest that some other characteristic, perhaps of the fish oil base used in the control diet caused the 
response. Further exploration of these responses is warranted as the optimal ratio of EPA to ARA to 
DHA is likely to be species and potentially size specific in barramundi (Sargent et al., 1999).  
In agreement with many vertebrates, nutritionally inducible COX2 genes have been identified in 
several teleost species (Ishikawa and Herschman, 2007; Ishikawa et al., 2007a; Montero et al., 
2015a; Olsen et al., 2012; Rouzer and Marnett, 2009; Yuan et al., 2015; Zuo et al., 2015). The role of 
COX2 as an active and rapidly inducible gene has undoubtedly played a role in the modified 
metabolic function of the ARA fed fish during the present study. The COX2 expression was 
significantly increased in both liver and kidney tissues suggesting that the highest inclusion of ARA 
was excessive or that the EPA to ARA ratio was unbalanced. 
To conclude, the present study supports that there is no phenotypic response by barramundi to the 
addition of either EPA or ARA to the diets. However, there are some metabolic changes to the 
retention and marginal utilisation efficiencies as a result of the diets. Increasing the dietary EPA or 
ARA level also modulated the expression of several eicosanoid metabolism and fatty acid oxidation 
genes. Investigation is warranted into the most appropriate balance of dietary LC-PUFA in light of 
the current levels of fish oil substitution in aquafeeds. Further refinements could also be made to 
factorial growth and feed utilisation models for barramundi with respect to specific fatty acids and 
their marginal utilisation efficiencies. 
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Table 1. Composition of key ingredients used in diet formulations (g/kg DM). Fatty acids are percentages of 
total fatty acids (%). 
 
Fish 
meal* 
Poultry 
meal 
Fish 
oil 
Palm 
flake 
Olive 
oil 
ARASCO®  
Incromega 
EPA 
TG500 
Incromega 
DHA 
TG500 
Dry matter (g/kg) 974 966 985 997 992 991 990 992 
Lipid 44 157 946 958 911 972 971 975 
Ash 191 151 ND ND ND ND ND ND 
Protein 684 660 7 7 5 10 6 5 
Energy (MJ/kg) 18.6 20.9 35.6 39.5 39.7 40.1 39.1 40.1 
16:0 27.0 23.8 22.5 47.4 10.4 9.3 ND 1.7 
18:0 6.3 8.6 5.2 51.3 4.0 8.3 ND 4.2 
18:1 16.1 41.9 19.5 ND 72.3 23.0 1.2 8.7 
18:2n-6 1.3 10.6 2.6 ND 10.8 7.2 ND 0.8 
18:3n-3 ND 1.4 1.2 ND 1.0 ND ND ND 
20:4n-6 1.1 1.2 1.6 ND ND 42.5 3.5 2.7 
20:5n-3 13.4 0.6 11.6 ND ND ND 70.2 9.2 
22:5n-3 3.3 0.4 2.1 ND ND 0.9 2.3 2.8 
22:6n-3 14.6 0.8 15.4 ND ND ND 17.5 64.6 
SFA 39.9 33.9 35.2 100.0 14.9 22.5 2.1 6.5 
MUFA 25.8 49.9 29.4 ND 73.3 23.0 4.6 13.3 
C18 PUFA 1.3 12.1 3.8 ND 11.8 7.2 ND 0.8 
LC-PUFA 32.5 4.0 30.8 ND ND 47.3 93.4 79.4 
n-3 31.3 3.3 30.3 ND 1.0 0.9 89.9 76.6 
n-6 2.4 12.8 4.2 ND 10.8 53.6 3.5 3.6 
* Fish meal was defatted prior to use. See methods for details. ND, not detected; GE, gross energy.  
18:1, sum of 18:1n-7, 18:1n-9 cis, 18:1n-9 trans; saturated fatty acids (SFA), sum of 12:0, 14:0, 16:0, 
18:0, 20:, 22:0, 24:0; monounsaturated fatty acids (MUFA), sum of 14:1n-5, 16:1n-7, 18:1n-7, 18:1n-9 
(cis and trans), 20:1n-7, 20:1n-9, 22:1n-9, 24:1n-9; polyunsaturated fatty acids, with 18 carbon atoms 
(C18 PUFA), sum 18:2n-6 (cis and trans), 18:3n-6, 18:3n-3, 18:4n-3; long chain polyunsaturated fatty 
acids, with 20 or more carbon atoms (LC-PUFA), sum 20:2n-6, 20:3n-6, 20:4n-6, 22:4n-6, 20:3n-3, 
20:5n-3, 22:5n-3, 22:6n-3; n-3, sum of omega 3 C18 PUFA and LC-PUFA; n-6, sum of omega 6 C18 
PUFA and LC-PUFA. 
 
  
Table 2. Formulation and composition of experimental diets (g/kg DM). Fatty acids are percentages of total fatty acids (%)   
  CTRL FO EPA 1.2 EPA 4.5 EPA 9.5 EPA 17.0 EPA 20.1 ARA 1.1 ARA 5.3 ARA 11.5 ARA 16.4 
Fish meal 1 150 150 150 150 150 150 150 150 150 150 
Poultry meal 1 97 97 97 97 97 97 97 97 97 97 
Casein 2 150 150 150 150 150 150 150 150 150 150 
Soy protein isolate 3 150 150 150 150 150 150 150 150 150 150 
Wheat gluten 3 150 150 150 150 150 150 150 150 150 150 
Wheat flour 3 150 150 150 150 150 150 150 150 150 150 
Pregel wheat starch 3 50 50 50 50 50 50 50 50 50 50 
Methionine 2 5 5 5 5 5 5 5 5 5 5 
Premix 4 6 6 6 6 6 6 6 6 6 6 
Dicalcium phosphate 5 5 5 5 5 5 5 5 5 5 
Choline chloride 2 2 2 2 2 2 2 2 2 2 
Stay-C 2 2 2 2 2 2 2 2 2 2 
Yttrium 5 1 1 1 1 1 1 1 1 1 1 
Fish oil 1 82.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Palm Flake 6 0.0 31.0 28.5 25.4 22.0 19.0 28.5 23.5 17.2 11.0 
Olive oil 6 0.0 38.7 36.0 31.9 28.0 24.0 36.0 30.0 21.9 13.7 
ARASCO® 7 0.0 2.3 1.8 1.2 0.5 0.0 1.8 13.0 27.6 42.2 
Incromega™ EPA TG500 8 0.0 0.0 7.7 18.2 29.0 39.0 7.7 7.5 7.1 6.9 
Incromega™ DHA TG500 8 0.0 10.0 8.0 5.3 2.5 0.0 8.0 8.0 8.2 8.2 
Composition 
          
Dry matter (g/kg) 959 961 959 955 946 950 959 952 961 963 
Lipid 90 100 96 106 96 94 96 92 97 96 
Ash 69 67 67 66 67 63 67 107 68 68 
Protein 577 586 566 584 563 559 566 568 577 596 
GE (MJ/kg) 21.8 21.6 21.7 21.5 21.4 21.3 21.7 21.6 21.7 21.7 
FA (mg/g lipid)^ 866.3 832.7 876.3 828.2 824.0 854.4 876.3 823.8 848.9 866.9 
16:0 22.4 25.8 25.6 18.9 18.7 17.7 25.6 20.3 17.7 15.8 
18:0 5.6 17.8 17.1 16.3 15.2 12.9 17.1 14.9 13.6 11.3 
18:1 21.4 33.6 31.4 29.4 29.3 26.8 31.4 31.3 29.1 26.4 
18:2n-6 9.9 10.3 10.4 11.7 6.7 9.5 10.4 11.7 9.9 10.6 
18:3n-3 1.5 0.8 0.8 1.2 0.7 1.0 0.8 1.0 0.8 0.8 
20:4n-6 1.5 1.3 1.1 1.3 1.3 1.9 1.1 5.3 11.5 16.4 
20:5n-3 8.9 1.2 4.5 9.5 17.0 20.1 4.5 5.7 5.3 5.6 
22:5n-3 1.7 0.5 0.5 0.9 0.8 0.9 0.5 0.6 0.8 0.9 
22:6n-3 11.5 4.8 5.2 5.6 6.3 5.8 5.2 5.4 6.5 5.6 
SFA 34.3 45.1 44.3 37.6 35.1 32.0 44.3 36.5 33.0 29.1 
MUFA 29.9 35.0 33.2 31.9 31.0 28.9 33.2 32.9 30.6 28.3 
C18 PUFA 11.4 11.6 11.3 13.1 7.4 10.5 11.3 13.1 11.5 12.5 
LC-PUFA 23.7 8.3 11.3 17.3 26.5 28.7 11.3 17.5 24.9 30.1 
n-3 23.7 7.3 11.0 17.3 26.0 27.8 11.0 12.7 13.3 12.8 
n-6 11.4 12.5 11.5 13.2 8.0 11.4 11.5 17.9 23.1 29.8 
^ Refer to Table 1 for definitions of fatty acids.  
1 Ridley Aquafeed, Narangba, QLD, Australia.         
2 Bulk Powders, www.bulkpowders.com.au 
         
3 Manildra Group, Rocklea, QLD, Australia 
         
4 Vitamin and mineral premix (IU kg-1 or g/kg of premix): vitamin A, 2.5MIU; vitamin D3, 0.25 MIU; vitamin E, 16.7 g; vitamin K3, 1.7 g; vitamin B1, 2.5 g; 
vitamin B2, 4.2 g; vitamin B3, 25 g; vitamin B5, 8.3; vitamin B6, 2.0 g; vitamin B9, 0.8; vitamin B12, 0.005 g; biotin, 0.17 g; vitamin C, 75 g; choline, 166.7 g; 
inositol, 58.3 g; ethoxyquin, 20.8 g; copper, 2.5 g; ferrous iron, 10.0 g; magnesium, 16.6 g; manganese, 15.0 g; zinc, 25.0 g 
5 Yttrium oxide, Stanford materials, Aliso Viejo, CA, 
USA.         
6 Sydney Essential Oil Co., Sydney, NSW, Australia 
        
7 ARASCO®, Martek Biosciences Co., Columbia, MD, USA. 
       
8 CRODA™, Snaith, East Yorkshire, UK. 
         
 
  
Table 3. Forward and reverse primer pairs (5ʹ – 3ʹ) used the cloning of eicosanoid metabolism genes 1 
in barramundi. 2 
Target   Abbreviation Genbank* Sequence (F/R) Product 
Degenerate primers 
 
Prostaglandin 
G/H synthase 
Lc COX-1a KU188276 TTTGGGAATGTACGCTACGC 752 bp 
   
GTGATAGAGGAGTATGTGCAGCA 
 
 
Prostaglandin 
G/H synthase 
Lc COX-1b KU188277 TCAGTGTGCGTTTCCAGTACAG 999 bp 
   
GGATTCTTTCTCCAGACAGC 
 
 
Prostaglandin 
G/H synthase 
Lc COX-2 KU188278 GTGATGTGCTGAAGGAGGTG 997 bp 
   
AGGATTGCGGACATTTCTTTCTC 
 
 
Arachidonate 5-
lipoxygenase 
Lc ALOX-5 KU188279 TTTACCATCGCCATCAACAC 976 bp 
   
GAGATGACGGCTACAGGGTG 
 * Genbank accession numbers 3 
 4 
Table 4. Forward and reverse primer pairs (5ʹ – 3ʹ) used in real-time qPCR expression analysis of 5 
eicosanoid metabolism genes 6 
Target Abbreviation EC number Sequence (F/R) Length 
RT- qPCR primers 
    
 
Prostaglandin G/H 
synthase 
Lc COX-1a 1.14.99.1 AACCGAGTCTGTGACATCCT 20 
 
  
CAACGTGGGATCAAACTTCAG 21 
 
Prostaglandin G/H 
synthase 
Lc COX-1b 1.14.99.1 CAGCCCTTCAATCAGTACAG 20 
 
  
TCTCACCGAATATGCTACCA 20 
 
Prostaglandin G/H 
synthase 
Lc COX-2 1.14.99.1 AGTTTGTCTTCAACACCTCTG 21 
 
  
ATTTCTCTGCTGTTCTCAATGG 22 
 
Arachidonate 5-
lipoxygenase 
Lc ALOX-5 1.13.11.34 TTTACCATCGCCATCAACACC 21 
 
  
CTCTTCCTTGCTGTCCACAC 20 
 
Carnitine 
palmitoyltransferase 
Lc CPT1a 2.3.1.21 TGATGGTTATGGGGTGTCCT 20 
 
  
CGGCTCTCTTCAACTTTGCT 20 
 
Luciferase Luc NA GGTGTTGGGCGCGTTATTTA 20 
 
   
CGGTAGGCTGCGAAATGC 18 
 
Elongation factor 1 
alpha 
EF1α NA AAATTGGCGGTATTGGAAC 19 
  
  
GGGAGCAAAGGTGACGAC 18 
NA, Not available 
 7 
  8 
Table 5. Growth performance and feed utilisation of barramundi fed increasing EPA analysed using 9 
polynomial contrasts. 10 
 11 
  12 
  Diets          Polynomial contrasts ^ 
 
EPA 
1.2 
EPA 
4.5 
EPA 
9.5 
EPA 
17.0 
EPA 
20.1 
P  
SEM 
Linear Quadratic Cubic 
Initial weight (g) 10.0 10.4 10.3 10.3 10.3 0.00 0.815 0.556 0.553 
Final weight (g) 55.6 53.8 54.2 53.6 53.6 0.40 0.126 0.437 0.550 
Weight gained (g) 45.3 43.5 43.9 43.3 43.3 0.40 0.126 0.413 0.526 
BW gain (%) 439.5 419.7 426.0 419.5 420.3 3.80 0.132 0.329 0.444 
Daily gain rate (g/d) 1.08 1.03 1.05 1.03 1.03 0.01 0.118 0.417 0.496 
Feed conversion 0.70 0.73 0.72 0.74 0.73 0.01 0.132 0.654 0.820 
Survival (%) 91.1 93.3 93.3 92.2 93.3 0.40 0.649 0.754 0.639 
^ Degrees of freedom 4, 10; linear, quadratic and cubic values are P values at an alpha level 
of 0.05.  
BW, Body weight, P SEM, Pooled standard error mean. 
 
  
Table 6. Growth performance and feed utilisation of barramundi fed increasing ARA analysed using 13 
polynomial contrasts. 14 
  Diets         Polynomial contrasts ^ 
 
ARA 
 1.1 
ARA 
 5.3 
ARA 
 11.5 
ARA 
 16.4 
P 
SEM 
Linear Quadratic Cubic 
Initial weight (g) 10.4 10.2 10.4 10.4 0.02 0.466 0.230 0.062 
Final weight (g) 53.8 53.7 53.2 54.8 0.51 0.435 0.209 0.357 
Weight gained (g) 43.5 43.5 42.8 44.4 0.52 0.466 0.239 0.299 
BW gain (%) 419.7 424.9 412.6 428.7 4.96 0.625 0.427 0.153 
Daily gain rate (g/d) 1.03 1.04 1.02 1.06 0.01 0.466 0.239 0.299 
Feed conversion 0.73 0.73 0.72 0.70 0.01 0.014 0.053 0.698 
Survival (%) 93.3 93.3 97.8 98.9 1.65 0.017 0.730 0.301 
^ Multiple R2 0.30, df 3,8; linear, quadratic and cubic values are P values at an alpha level of 0.05.  
BW, Body weight; P SEM, Pooled standard error mean. 
 15 
 16 
 17 
  18 
Table X. Growth performance and feed utilisation of barramundi fed EPA and ARA diets analysed by 19 
one-way ANOVA. 20 
 
EPA 
1.2 
EPA 
9.5 
EPA 
20.1 
ARA 
1.1 
ARA 
16.4 
FO 
CTR
L 
P 
SE
M 
F  
Valu
e 
P  
Value
^ 
Initial weight (g) 10.3 10.3 10.3 10.4 10.4 10.3 0.01 0.57 0.717 
Final weight (g) 55.6 54.2 53.6 53.8 54.8 56.1 0.31 2.29 0.112 
Weight gained (g) 45.3 43.9 43.3 43.5 44.4 45.8 0.31 2.33 0.106 
BW gain (%) 
439.
5 
426.
0 
420.
3 
419.
7 
428.
7 
442.3 2.99 2.41 0.098 
Daily gain rate (g/d) 1.08 1.05 1.03 1.03 1.06 1.09 0.01 2.33 0.106 
Feed conversion 0.70 0.72 0.73 0.73 0.70 0.69 0.01 2.09 0.137 
Survival (%) 91.1 93.3 93.3 93.3 98.9 91.1 0.01 1.85 0.178 
^ Degrees of freedom 5, 
12. 
 
    
    
BW, Body weight, P SEM, Pooled standard error mean. 
 
 21 
  22 
Table 7. Apparent digestibility (%) of nutrients and fatty acids in diets analysed by one-way ANOVA. 23 
 
EPA 
1.2 
EPA 
9.5 
EPA 
20.1 
ARA 
1.1 
ARA 
16.4 
FO 
CTRL 
P 
SEM 
F  
value 
P  
Value^ 
Dry matter 70.2 69.1 74.0 70.8 67.3 69.2 1.1 0.46 0.800 
Protein 92.3 91.7 93.1 92.0 91.1 92.4 0.3 1.05 0.435 
Lipid 79.3 a 85.2 a 89.3 ab 78.3 a 86.4 a 94.9 b 1.6 11.12 0.001 
Energy 82.3 79.2 84.7 80.0 81.1 83.3 0.8 1.27 0.340 
16:0 70.1 52.7 51.4 63.6 51.8 63.8 2.7 1.64 0.223 
18:0 64.9 a 42.1 cd 28.2 d 53.8 abc 30.7 d 56.8 abc 3.5 16.56 0.000 
18:1 92.1 ab 93.1 a 94.7 a 89.3 ab 93.3 a 84.1 b 1.0 4.87 0.014 
18:2n-6 95.9 ab 94.9 ab 97.0 a 94.4 ab 95.3 ab 92.5 b 0.4 4.31 0.017 
18:3n-3 100.0 100.0 100.0 100.0 100.0 100.0 0.0 NA NA 
20:4n-6 100.0 100.0 99.0 100.0 96.9 100.0 0.3 NA NA 
20:5n-3 100.0 97.8 ab 99.2 b 96.1 a 97.6 ab 96.7 a 0.4 8.70 0.002 
22:5n-3 100.0 100.0 100.0 100.0 95.3 90.4 1.1 NA NA 
22:6n-3 95.6 96 97.9 92.9 95.8 95.7 0.5 2.74 0.071 
SFA 71.3 a 54.5 ab 49.6 b 63.9 ab 50.7 b 66.9 ab 2.4 4.89 0.011 
MUFA 92.4 a 93.6 a 96.0 a 89.8 ab 93.3 a 83.7 b 1.1 8.10 0.002 
C18 PUFA 96.3 a 95.4 ab 97.3 a 94.9 ab 96.0 ab 93.5 b 0.4 5.07 0.010 
LC-PUFA 98.2 a 98.2 a 98.9 a 94.5 c 96.9 ab 95.9 bc 0.4 10.16 0.000 
n-3 96.9 ab 98.2 a 98.9 a 94.4 c 96.7 ab 95.9 bc 0.4 7.88 0.002 
n-6 97.6 a 95.6 ab 97.4 a 95.1 ab 96.6 a 93.5 b 0.4 7.60 0.002 
^ Degrees of freedom 5, 12. 
P SEM, Pooled standard error mean. 
 24 
  25 
Table 8. Whole body and fatty acid composition of barramundi analysed by one-way ANOVA (g/kg 26 
live-basis). 27 
  
Initial 
fish 
EPA 
1.2 
EPA 
9.5 
EPA 
20.1 
ARA  
1.1 
ARA 
16.4 
FO 
CTRL 
P 
SEM 
F 
statistic 
P 
value^ 
Dry matter 225.4 266.2a 280.6 ab 284.6 b 275.3 ab 280.4 ab 287.5 b 2.0 4.95 0.011 
Protein 144.4 173.0 182.3 181.1 182.2 178.0 177.4 1.5 0.95 0.482 
Lipid 32.9 55.0 a 63.9 b 66.0 b 61.2 ab 67.5 bc 73.5 c 1.5 12.7 0.000 
Energy (MJ/kg) 47.2 59.9 a 67.0 b 66.4 b 65.2 ab 66.6 b 67.3 b 0.8 4.50 0.015 
16:0 5.5 9.5 a 10.2 a 9.9 a 10.2 a 9.7 a 13.7 b 0.4 36.0 0.000 
18:0 1.8 2.9 a 3.4 b 3.0 ab 3.1 ab 3.5 c 3.5 c 0.1 7.51 0.002 
18:1 7.7 15.1 16.4 15.1 16.5 14.5 14.4 0.3 3.32 0.041 
18:2n-6 2.4 4.8 5.1 5.1 5.2 5.3 4.9 0.1 1.28 0.333 
18:3n-3 0.3 0.4 a 0.4 a 0.5 b 0.4 ab 0.4 a 0.6 c 0.0 33.05 0.000 
20:4n-6 0.2 0.4 a 0.5 a 0.5 a 0.5 a 5.3 b 0.5 a 0.5 1638.9 0.000 
20:5n-3 0.7 0.5 a 2.7 c 5.6 d 1.3 b 1.5 b 2.4 c 0.5 186.1 0.000 
22:5n-3 0.3 0.4 a 1.0 c 1.3 d 0.7 b 0.7 b 1.2 d 0.1 108.9 0.000 
22:6n-3 1.4 1.9 a 2.3 a 2.4 a 2.1 a 2.4 a 4.2 b 0.2 82.93 0.000 
SFA 8.2 13.1 a 14.3 a 13.9 a 14.1 a 13.9 a 19.4 b 0.5 38.90 0.000 
MUFA 9.3 16.6 18.0 16.6 18.1 16.0 18.0 0.3 2.92 0.059 
PUFA 2.8 5.5 5.8 5.9 5.9 6.3 5.8 0.1 2.08 0.139 
LC-PUFA 2.5 3.3 a 6.6 c 9.8 e 4.8 b 10.9 e 8.3 d 0.7 108.47 0.000 
n-3 2.6 3.1 a 6.4 c 9.8 e 4.6 b 4.9 b 8.3 d 0.6 98.78 0.000 
n-6 2.7 5.7 a 6.0 a 5.9 a 6.1 a 12.3 b 5.7 a 0.6 152.3 0.000 
^ Degrees of freedom 5, 12. 
P SEM, Pooled standard error mean. 
 
 28 
  29 
Table 9. Retention efficiency of selected fatty acids in barramundi fed either increasing EPA or ARA 30 
analysed by polynomial contrasts. 31 
  EPA Polynomial contrasts ^ ARA Polynomial contrasts ^ 
  Linear Quadratic Cubic Linear Quadratic Cubic 
18:2n-6 retention 0.000 0.242 0.006 0.000 0.660 0.001 
18:3n-3 retention 0.020 0.989 0.104 0.001 0.094 0.001 
20:4n-6 retention 0.057 0.006 0.209 0.911 0.000 0.178 
20:5n-3 retention 0.167 0.047 0.165 0.303 0.339 0.682 
22:6n-3 retention 0.965 0.201 0.061 0.004 0.006 0.180 
^ Degrees of freedom EPA 4, 10; ARA 3, 8; linear, quadratic and cubic values are P values at an alpha 
level of 0.05. 
 32 
Table 10. Summary of maintenance demand and utilisation efficiencies by barramundi fed either 33 
increasing EPA or ARA. 34 
 
Maintenance 
demand (g/kg LWx/t) 
Efficiency constant 
 k 
Intake:Gain  
ratio 
R2 P value 
20:5n-3; EPA 0.000 0.621 1.610 0.975 <0.01 
20:4n-6; ARA 0.011 0.919 1.088 0.966 <0.05 
  
 35 
  36 
 37 
Figure 1. Specific fatty acid retention efficiency by barramundi fed increasing EPA (a-e) or 38 
ARA (f-j). The control (FO CTRL) fed fish are represented in each figure with a triangle (∆). 39 
Bars indicate standard error means (n=3). 40 
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 42 
Figure 2. Marginal utilisation efficiency assessments of 20:5n-3 (a) and 20:4n-6 (b) gain with 43 
varying intake by juvenile barramundi. Efficiency functions are described by the linear 44 
regression for 20:5n-3 gain y = 0.621x + 0.0003, R2 = 0.975 and 20:4n-6 gain y = 0.919x - 45 
0.011, R2 = 0.965). 46 
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 48 
Figure 3. Eicosanoid pathway and mitochondrial fatty acid oxidation gene expression in the 49 
liver (L) and kidney (K) of juvenile barramundi fed increasing EPA. Gene expression is 50 
normalised to the EF1α and Luc reference genes. Data were analysed by one-way ANOVA 51 
(df 4,28) with letters above bars indicating differences defined as P<0.05. 52 
 53 
 54 
 55 
Figure 4. Eicosanoid pathway and mitochondrial fatty acid oxidation gene expression in the 56 
liver (L) and kidney (K) of juvenile barramundi fed increasing ARA. Gene expression is 57 
normalised to the EF1α and Luc reference genes. Data were analysed by one-way ANOVA 58 
(df 4,28) with letters above bars indicating differences defined as P<0.05. 59 
 60 
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